Tag

Novartis

40 to 90 percent profit margins Astronomical profit margins of pharmaceutical companies are partly to blame for the premium shock

12. September 2022

Report Big Pharma takes it all

Patent abuse, lack of transparency, profiteering How Covid-19 exposes Big Pharma’s harmful business strategies

9. March 2021

Affordable drugs How dare you, Novartis?

28. February 2020

Affordable drugs Novartis cancer treatment for CHF 370,000?! Public Eye opposes Kymriah patent

3. July 2019

Clinical trials Roche and Novartis neglect their ethical responsibility in emerging countries

20. May 2019

Press Release Compulsory licensing in Colombia: Aggressive lobbying by Novartis

12. April 2017

News Glivec in Colombia: new leaked letter from Novartis attests to pressure at highest level

11. December 2015

Press Release Joint Open Letter Calling Novartis to cease seemingly endless legal process in India

22. February 2011

Press Release The Berne Declaration welcomes the Indian justice’s decision and demands that Novartis and Switzerland respect this decision

6. August 2007